Correction: Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data - Top-Institutions - MDSpire

Correction: Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data

  • By

  • Hao Dong

  • Jianliang Miao

  • Zhong Liu

  • Yuguang Sun

  • Peilin Li

  • Song Xia

  • Wenbin Shen

  • July 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Johns Hopkins Kimmel Cancer Center
    Johns Hopkins Kimmel Cancer Center

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #4

    The First Affiliated Hospital of Dalian Medical University
    The First Affiliated Hospital of Dalian Medical University

    Dalian, Liaoning

    Key Differentiators

    • Oncology

  • #5

    Beijing Shijitan Hospital
    Beijing Shijitan Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

Original Source(s)

Correction: Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data

  • by Hao Dong, Jianliang Miao, Zhong Liu, Yuguang Sun, Peilin Li, Song Xia, Wenbin Shen

  • July 9, 2026

Related Content

Translational AI in whole-slide image cancer histopathology: state of the art and regulatory-approved solutions

Retraction Note: Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma

Clinical features and treatment challenges of HER2-positive primary breast squamous cell carcinoma: a case report and literature review